REGISTERED
on 05 Jul 2022
Last Applicant/ Owned by
170 Park Avenue
Florham Park
NJ
07932
Serial Number
97265958 filed on 14th Feb 2022
Registration Number
6782542 registered on 05th Jul 2022
Correspondent Address
Camille M. Miller
Filing Basis
1. use application currently
Disclaimer
NO DATA
CELULARITY
Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
Classification Information
Class [040]
Treatment & Processing of Materials Services
Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
First Use Date in General
21st Feb 2018
First Use Date in Commerce
21st Feb 2018
Mark Details
Serial Number
No 97265958
Mark Type
No Service Mark
Attorney Docket Number
No CLTY0512US3
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Jul 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 05th Jul 2022 | REGISTERED-PRINCIPAL REGISTER |
| 19th Apr 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Apr 2022 | PUBLISHED FOR OPPOSITION |
| 30th Mar 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 15th Mar 2022 | ASSIGNED TO LIE |
| 11th Mar 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 11th Mar 2022 | EXAMINER'S AMENDMENT ENTERED |
| 11th Mar 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 11th Mar 2022 | EXAMINERS AMENDMENT E-MAILED |